Patterson To Carry MediVet Stem Cell Products

Patterson to Carry MediVet Stem Cell Products

Stem cell therapy for animals has been commercially available since 2004, according to MediVet America.

The companies reached agreement on the distribution of stem cell and platelet-rich plasma kits and associated tissue-processing equipment to veterinary practices nationwide.

Jeff Baker, vice president of sales at Devens, Mass.-based Patterson, called MediVet "a forward-thinking company that is a leader in the emerging regenerative therapy segment.”

"MediVet’s line of stem cell therapies and equipment is a strong addition to the Patterson Veterinary portfolio of cutting-edge technologies,” Baker said.

The companies have developed an educational platform designed to help veterinarians learn about stem cell therapy.

More than 550 veterinarians in 47 states perform in-clinic stem cell procedures, noted MediVet, which is headquartered in Nicholasville, Ky.

Adult animal stem cell technology uses the body’s regenerative healing power to treat dogs, cats, horses and other animals suffering from arthritis, hip dysplasia, tendon, ligament and cartilage injuries, and other ailments. The stem cell kit allows for same-day harvest and application of repair cells derived from an animal’s fat tissue.

MediVet stem cell technology also is distributed by Henry Schein Animal Health of Dublin, Ohio.


Leave a Comment


Your email address will not be published. Required fields are marked *


Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.